Salesforce Ventures and returning investor Slack Fund helped the virtual event provider add series A funding to the seed round it closed four months ago.

Syncona supplied a third of the investment and retains a majority stake in Freeline, which is based on research at UCL.

Wuxi AppTec and Pfizer contributed to a series A round that will support progress of Simcha Therapeutics' immuno-oncology treatments toward clinical trials.

Up Optotech-backed laser-diode chip foundry Everbright Photonics secured $21.2m in a round led by brokerage Huatai Securities.

Chinese Academy of Sciences-backed laser-diode chip foundry Everbright Photonics has now raised $63.3m since it was founded in 2012.

SoftBank Vision Fund made its first investment in Baidu's online education spinoff as part of a series E round reportedly set to value it at $6.5bn pre-money.

OneProjects, an irregular heartbeat imaging system developer assisted by two Irish universities, will use the cash to pursue commercialisation in the US.

The health insurance provider pushed its overall funding past $1.5bn in a late-stage round that included long-term investor Alphabet.

The endpoint management software provider has secured roughly $120m from strategic partner Salesforce, bumping its valuation up from $6.5bn to $9bn.

Novartis and Transposagen-backed gene and cell therapy developer Poseida Therapeutics closed the series D round two days after filing to go public.